Basal CD34+ cell count predicts peripheral blood progenitor cell mobilisation and collection in healthy donors after administration of granulocyte colony-stimulating factor

Haematologica

Volumn 89, Issue 12, 2004, Pages 1530-1532

  De La Rubia, Javier ^a   Lorenzo, José I ^a   Torrabadella, Marta ^a   Marín, Pedro ^a   Insunza, Andrés ^a   Sanz, Miguel A ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

CD34+ cell count; G CSF; Mobilization; Prediction

Indexed keywords

CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; AGE; AGED; APHERESIS; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CELL COUNT; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; LEUKAPHERESIS; LEUKOCYTE COUNT; LOGISTIC REGRESSION ANALYSIS; MALE; MULTIVARIATE ANALYSIS; PERIPHERAL BLOOD STEM CELL; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; STEADY STATE; STEM CELL MOBILIZATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTIGENS, CD34; BLOOD CELL COUNT; CHILD; CHILD, PRESCHOOL; FEMALE; FILGRASTIM; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKAPHERESIS; MALE; MIDDLE AGED; SEX FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 10444264457     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Anderlini P, Przepiorka D, Champlin R, Körbling M. Biologic and clinical effects of granulocyte-colony stimulating factor in normal individuals. Blood 1996;88:2819-25.
2. + cells in normal donors treated with filgrastim. Transfusion 1997;37:507-12.
3. Miflin G, Charely C, Stainer C, Anderson S, Hunter A, Russell N. Stem cell mobilization in normal donors for allogeneic transplantation: analysis of safety and factors affecting efficacy. Br J Haematol 1996;95:345-8.
4. De la Rubia J, Arbona C, de Arriba F, del Cañizo F, Brunet S, Zamora C, et al. Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors. Transfusion 2002;42:4-9.
5. Brown RA, Adkins D, Goodnough LT, Haugh JS, Todd G, Wehde M, et al. Factors that influence the collection and engraftment of allogeneic peripheral-blood stem cells in patients with hematologic malignancies. J Clin Oncol 1997;15:3067-74.
6. + cell counts based on the ISHAGE Guidelines. Cytometry 1998;34:61-70.
7. Anderlini P, Donato M, Chan KW, Huh YO, Gee AP, Lauppe MJ, et al. Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Cancer Center experience. Transfusion 1999;39:555-60.
8. De la Rubia J, Díaz MA, Verdeguer A, Pascual MJ, Arbona C, Arrieta R, et al. Donor age related differences in peripheral blood progenitor mobilization with recombinant human granulocyte-colony stimulating factor (rHuG-CSF). Transfusion 2001;41:201-5.
9. Díaz MA, Sevilla J, de la Rubia J, Verdeguer A, Espigado I, Vicent MG, et al. Factors predicting peripheral blood collection from pediatric donors for allogeneic transplantation. Haematologica 2003;88:919-22.
10. + cells in normal donors treated with filgrastim. Transfusion 1997;37:507-12.
11. Luider J, Brown C, Selinger S, Quinlan D, Karlsson L, Ruether D, et al. Factors influencing yields of progenitor cells for allogeneic transplantation: optimization of G-CSF dose, day of collection, and duration of leukapheresis. J Hematother 1997;6:575-80.